News | Stroke | March 19, 2019

Co-founder of iSchemaView led DEFUSE 3 Study that contributed to new AHA/ASA thrombectomy guidelines


Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research

March 19, 2019 – iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research Achievement Award, presented by the Clinical Research Forum. The Distinguished Clinical Research Achievement Awards are presented to the top two studies that show creativity, innovation, or a novel approach that demonstrates an immediate impact on the health and well-being of patients.

In the DEFUSE 3 study, Albers and his team used iSchemaView’s RAPID advanced medical imaging platform, exclusively, to identify stroke patients who continue to have salvageable brain tissue many hours after stroke onset. By identifying patients who are most likely to benefit from stroke therapies, the DEFUSE 3 study is credited with accelerating the development and testing of new therapeutic options, as well as enabling hospitals to offer life-saving stroke therapies to many patients who arrive after the previous standard six-hour treatment window has elapsed.

Albers is the Coyote Foundation professor of neurology and neurological sciences and professor, by courtesy, of neurosurgery at the Stanford University Medical Center. He is also director of the Stanford Stroke Center. Albers’ primary research focus is the diagnosis, management and prevention of ischemic stroke. He was instrumental in the development of RAPID, a medical imaging platform that allows physicians to identify stroke patients who have salvageable brain tissue. Due to the findings of DEFUSE 3 and other stroke studies that also employed RAPID, the American Heart Association and American Stroke Association changed their treatment guidelines for thrombectomy from six hours after onset to up to 24 hours after onset for patients with salvageable brain tissue.

Following the awards ceremony, Albers will present the results of the DEFUSE 3 study to members of Congress and discuss the critical role of federal funding for clinical research.

Read the article "Brain-Scan Guided Emergency Stroke Treatment Can Save More Lives"

For more information:

Related Content

News | Neuro Imaging

July 2, 2021 — Researchers at the University of Chicago and the U.S. Department of Energy's (DOE) Argonne National ...

Time July 02, 2021
News | Stroke

December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA ...

Time December 01, 2020
Videos | Artificial Intelligence

Pooja Rao, Ph.D., co-founder of Qure.AI and head of research and development for the company, explains how the company's ...

Time July 31, 2020
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

Four recent radiology studies, from New York, Italy, Iran and China, show how COVID-19 (SARS-CoV-2) impacts the brain of ...

Time July 06, 2020
Videos | Stroke

Ajay Choudhri, M.D., chairman of radiology, Capital Health, Hopewell, N.J., explains his center's experience using an ...

Time January 03, 2020
News | Nuclear Imaging

December 26, 2019 — The Feinstein Institutes for Medical Research has received U.S. Food and Drug Administration (FDA) ...

Time December 26, 2019
News | Magnetic Resonance Imaging (MRI)

November 28, 2019 — Individuals with functional neurological disorder (FND) have symptoms not explained by traditional ...

Time November 28, 2019
News | Clinical Trials

October 29, 2019 — A UCLA-led study finds that, with the use of magnetic resonance imaging (MRI) scans, it is possible ...

Time October 29, 2019
News | Artificial Intelligence

To help advance medical research while preserving data privacy and improving patient outcomes for brain tumor identification, NVIDIA researchers in collaboration with King’s College London researchers recently announced the introduction of the first privacy-preserving federated learning system for medical image analysis. NVIDIA is working with King’s College London and French startup Owkin to enable federated learning for the newly established London Medical Imaging and AI Centre for Value Based Healthcare.

Time October 23, 2019
News | Artificial Intelligence

Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that its Accipio intracranial hemorrhage (ICH) and stroke software will be integrated on Philips’ computed tomography (CT) systems. The integration of Accipio’s AI-powered solutions into Philips CT systems will support the detection of ICH to augment caregivers in identifying and prioritizing patients suffering from stroke, traumatic brain injury, head trauma and other life-threatening conditions.

Time October 18, 2019
Subscribe Now